DiaSorin S.p.A. (DSRLF)
USD 109.01
(0.0%)
USD 109.01
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 741.18 Million EUR | -16.51% |
| 2022 | 884.56 Million USD | -0.49% |
| 2021 | 888.92 Million USD | 24.75% |
| 2020 | 712.56 Million USD | 37.36% |
| 2019 | 518.76 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 362.65 Million EUR | 3.09% |
| 2024 Q1 | 207.18 Million EUR | -1.63% |
| 2023 FY | 738.49 Million USD | -16.51% |
| 2023 Q2 | 384.96 Million USD | 100.61% |
| 2023 Q4 | 334.67 Million USD | 99.21% |
| 2023 Q1 | 191.9 Million EUR | -57.61% |
| 2023 Q3 | 168 Million EUR | -56.36% |
| 2022 Q2 | 424.18 Million USD | 63.3% |
| 2022 Q1 | 259.76 Million EUR | -41.28% |
| 2022 FY | 884.56 Million USD | -0.49% |
| 2022 Q4 | 452.66 Million USD | 104.83% |
| 2022 Q3 | 221 Million EUR | -47.9% |
| 2021 Q1 | 217.11 Million EUR | -34.7% |
| 2021 Q2 | 353.01 Million EUR | 62.59% |
| 2021 Q3 | 260.13 Million EUR | -26.31% |
| 2021 Q4 | 442.36 Million EUR | 70.05% |
| 2021 FY | 888.92 Million USD | 24.75% |
| 2020 Q2 | 254.69 Million EUR | 91.64% |
| 2020 Q4 | 332.48 Million EUR | 82.11% |
| 2020 Q3 | 182.57 Million EUR | -28.32% |
| 2020 FY | 712.56 Million USD | 37.36% |
| 2020 Q1 | 132.9 Million EUR | -43.61% |
| 2019 Q1 | 133.14 Million EUR | -2.96% |
| 2019 FY | 518.76 Million USD | 0.0% |
| 2019 Q4 | 235.71 Million EUR | 80.5% |
| 2019 Q3 | 130.58 Million EUR | -51.06% |
| 2019 Q2 | 266.81 Million EUR | 100.39% |
| 2018 Q2 | 135.03 Million EUR | -1.42% |
| 2018 Q1 | 136.97 Million EUR | 1.76% |
| 2018 Q4 | 137.2 Million EUR | 8.23% |
| 2018 Q3 | 126.77 Million EUR | -6.12% |
| 2017 Q3 | 118.78 Million EUR | -6.48% |
| 2017 Q1 | 115.22 Million EUR | 2.57% |
| 2017 Q4 | 134.6 Million EUR | 13.33% |
| 2017 Q2 | 127.01 Million EUR | 10.23% |
| 2016 Q4 | 112.33 Million EUR | 0.92% |
| 2016 Q2 | 108.34 Million EUR | 10.92% |
| 2016 Q1 | 97.67 Million EUR | -0.66% |
| 2016 Q3 | 111.31 Million EUR | 2.74% |
| 2015 Q2 | 97.2 Million EUR | 14.43% |
| 2015 Q3 | 94.89 Million EUR | -2.37% |
| 2015 Q4 | 98.32 Million EUR | 3.61% |
| 2015 Q1 | 84.94 Million EUR | -12.72% |
| 2014 Q2 | 101.52 Million EUR | 2.68% |
| 2014 Q3 | 91.4 Million EUR | -9.97% |
| 2014 Q4 | 97.32 Million EUR | 6.48% |
| 2014 Q1 | 98.86 Million EUR | -6.87% |
| 2013 Q2 | 103.79 Million EUR | 12.43% |
| 2013 Q4 | 106.15 Million EUR | 10.97% |
| 2013 Q1 | 92.31 Million EUR | 0.0% |
| 2013 Q3 | 95.66 Million EUR | -7.83% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| American Bio Medica Corporation | -193 Thousand USD | 384134.197% |
| Arrayit Corporation | 2.57 Million USD | -28683.274% |
| Atlantic International Corp. | -154.23 Thousand USD | 480659.41% |
| Biocept, Inc. | -2.58 Million USD | 28805.887% |
| Bioqual, Inc. | 7.42 Million USD | -9876.75% |
| CardioGenics Holdings Inc | - USD | -Infinity% |
| DermTech, Inc. | 276 Thousand USD | -268445.652% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 6.73 Billion USD | 89.003% |
| HTG Molecular Diagnostics, Inc. | 1.79 Million USD | -41212.735% |
| iMD Companies, Inc. | -23.63 Thousand USD | 3135802.5% |
| IDenta Corp. | 662.97 Thousand USD | -111696.976% |
| Interpace Biosciences, Inc. | 23.04 Million USD | -3116.534% |
| Integrative Health Technologies, Inc. | 77.57 Thousand USD | -955393.677% |
| InVitro International | 635.98 Thousand USD | -116441.428% |
| Lumos Diagnostics Holdings Limited | 6.56 Million USD | -11193.402% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 1.09 Million USD | -67731.688% |
| NovelStem International Corp. | 12 Thousand USD | -6176450.0% |
| Optigenex Inc. | -102.96 Thousand USD | 719935.674% |
| PharmChem, Inc. | 3.9 Million USD | -18883.469% |
| Proteome Sciences plc | 2.09 Million USD | -35251.285% |
| Response Genetics, Inc | 3.94 Million USD | -18702.283% |
| Rennova Health, Inc. | 6.26 Million USD | -11724.447% |
| RushNet, Inc. | 1.1 Million USD | -66999.035% |
| ScreenPro Security Inc. | 856.57 Thousand USD | -86429.126% |
| Stella Diagnostics Inc. | - USD | -Infinity% |
| StageZero Life Sciences Ltd. | -403.74 Thousand USD | 183676.844% |
| Todos Medical Ltd. | 4.31 Million USD | -17096.891% |